Higher biopsy rates for women undergoing screening breast MRI

February 14, 2018

(HealthDay)—Women undergoing screening breast magnetic resonance imaging (MRI) have higher biopsy rates and significantly lower cancer yield findings compared with screening mammography alone, regardless of personal history of breast cancer (PHBC), according to a study published online Feb. 12 in JAMA Internal Medicine.

Diana S.M. Buist, Ph.D., M.P.H., from the Kaiser Permanente Washington Health Research Institute in Seattle, and colleagues conducted an observational cohort study of six Breast Cancer Surveillance Consortium registries. Data were included for a sample of 812,164 women undergoing a total of 2,048,994 digital and/or breast MRI screening episodes from 2003 through 2013. Outcomes were stratified by PHBC.

The researchers found that for women with PHBC, age-adjusted core and surgical biopsy rates were doubled after MRI versus mammography (57.1 versus 23.6 per 1,000 episodes). The differences were even larger for women without PHBC (84.7 and 14.9 per 1,000 episodes, respectively). In women with PHBC, the ductal carcinoma in situ and invasive biopsy yield was significantly higher after mammography versus MRI episodes (404.6 versus 267.6 per 1,000 episodes); for women without PHBC, the yield was nonsignificantly higher (279.3 versus 214.6 per 1,000 episodes). Regardless of PHBC, high-risk benign lesions were more commonly identified after MRI.

"Further work is needed to identify who will benefit from screening MRI to ensure an acceptable benefit-to-harm ratio," the authors write.

Explore further: Including diagnosis related costs, 3-D mammography costs less than digital mammography

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Including diagnosis related costs, 3-D mammography costs less than digital mammography

December 8, 2017
Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it actually may help rein in cancer screening costs, according to preliminary findings (PD7-05) presented ...

False-positive mammography results are common

January 12, 2016
(HealthDay)—For women undergoing digital mammography screening, false-positive results are common, especially among younger women and those with risk factors, according to research published online Jan. 12 in the Annals ...

Community practices not following guidelines for MRI breast cancer screening

December 7, 2017
Guidelines are not being followed to ensure that breast cancer screening of high risk women, such as those with a strong family history of breast cancer, includes an additional MRI (magnetic resonance imaging) scan. According ...

Women prefer getting mammograms every year

November 21, 2017
Women prefer to get their mammograms every year, instead of every two years, according to a new study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?

June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy ...

Recommended for you

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.